|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Panebianco V, Sciarra A, Marcantonio A,
Forte V, Biondi T, Laghi A and Catalano C: Conventional imaging and
multiparametric magnetic resonance (MRI, MRS, DWI, MRP) in the
diagnosis of prostate cancer. Q J Nucl Med Mol Imaging. 56:331–342.
2012.PubMed/NCBI
|
|
3
|
Cusan L: Prostate cancer screening with
PSA, DRE and TRUS. Can J Oncol. 4 (Suppl 1):S63–S64. 1994.
|
|
4
|
Crowell PD and Goldstein AS: Functional
evidence that progenitor cells near sites of inflammation are
precursors for aggressive prostate cancer. Mol Cell Oncol.
4:e12797232017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Shafique K, Proctor MJ, McMillan DC,
Qureshi K, Leung H and Morrison DS: Systemic inflammation and
survival of patients with prostate cancer: Evidence from the
glasgow inflammation outcome study. Prostate Cancer Prostatic Dis.
15:195–201. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sfanos KS and De Marzo AM: Prostate cancer
and inflammation: The evidence. Histopathology. 60:199–215. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Han ZG, Zhang QH, Ye M, Kan LX, Gu BW, He
KL, Shi SL, Zhou J, Fu G, Mao M, et al: Molecular cloning of six
novel Krüppel-like zinc finger genes from hematopoietic cells and
identification of a novel transregulatory domain KRNB. J Biol Chem.
274:35741–35748. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Edelstein LC and Collins T: The SCAN
domain family of zinc finger transcription factors. Gene. 359:1–17.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang H, Sun R, Liu G, Yao M, Fei J and
Shen H: Characterization of the target DNA sequence for the
DNA-binding domain of zinc finger protein 191. Acta Biochim Biophys
Sin (Shanghai). 40:704–710. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Khalfallah O, Faucon-Biguet N, Nardelli J,
Meloni R and Mallet J: Expression of the transcription factor
Zfp191 during embryonic development in the mouse. Gene Expr
Patterns. 8:148–154. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Prost JF, Nègre D, Cornet-Javaux F, Cortay
JC, Cozzone AJ, Herbage D and Mallein-Gerin F: Isolation, cloning,
and expression of a new murine zinc finger encoding gene. Biochim
Biophys Acta. 1447:278–283. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Howng SY, Avila RL, Emery B, Traka M, Lin
W, Watkins T, Cook S, Bronson R, Davisson M, Barres BA and Popko B:
ZFP191 is required by oligodendrocytes for CNS myelination. Genes
Dev. 24:301–311. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li J, Chen X, Yang H, Wang S, Guo B, Yu L,
Wang Z and Fu J: The zinc finger transcription factor 191 is
required for early embryonic development and cell proliferation.
Exp Cell Res. 312:3990–3998. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu G, Jiang S, Wang C, Jiang W, Liu Z,
Liu C, Saiyin H, Yang X, Shen S, Jiang D, et al: Zinc finger
transcription factor 191, directly binding to β-catenin promoter,
promotes cell proliferation of hepatocellular carcinoma.
Hepatology. 55:1830–1839. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu X, Ge X, Zhang Z, Zhang X, Chang J, Wu
Z, Tang W, Gan L, Sun M and Li J: MicroRNA-940 promotes tumor cell
invasion and metastasis by downregulating ZNF24 in gastric cancer.
Oncotarget. 6:25418–25428. 2015.PubMed/NCBI
|
|
16
|
Khalfallah O, Ravassard P, Lagache CS,
Fligny C, Serre A, Bayard E, Faucon-Biguet N, Mallet J, Meloni R
and Nardelli J: Zinc finger protein 191 (ZNF191/Zfp191) is
necessary to maintain neural cells as cycling progenitors. Stem
Cells. 27:1643–1653. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lv L, Zhang J, Wang P, Meng Q, Liang W and
Zhang L: Zinc finger protein 191 deficiency attenuates vascular
smooth muscle cell proliferation, migration, and intimal
hyperplasia after endovascular arterial injury. J Vasc Surg.
59:500–509. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial- mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Thiery JP: Epithelial-mesenchymal
transitions in development and pathologies. Curr Opin Cell Biol.
15:740–746. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yao D, Dai C and Peng S: Mechanism of the
mesenchymal-epithelial transition and its relationship with
metastatic tumor formation. Mol Cancer Res. 9:1608–1620. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang X, Ling MT, Guan XY, Tsao SW, Cheung
HW, Lee DT and Wong YC: Identification of a novel function of
TWIST, a bHLH protein, in the development of acquired taxol
resistance in human cancer cells. Oncogene. 23:474–482. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yang J and Weinberg RA:
Epithelial-mesenchymal transition: At the crossroads of development
and tumor metastasis. Dev Cell. 14:818–829. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Epstein JI, Egevad L, Amin MB, Delahunt B,
Srigley JR and Humphrey PA; Grading Committee, : The 2014
international society of urological pathology (ISUP) consensus
conference on gleason grading of prostatic carcinoma: Definition of
grading patterns and proposal for a new grading system. Am J Surg
Pathol. 40:244–252. 2016.PubMed/NCBI
|
|
25
|
Buyyounouski MK, Choyke PL, McKenney JK,
Sartor O, Sandler HM, Amin MB, Kattan MW and Lin DW: Prostate
cancer-major changes in the American joint committee on cancer
eighth edition cancer staging manual. CA Cancer J Clin. 67:245–253.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Roy R, Rodig S, Bielenberg D, Zurakowski D
and Moses MA: ADAM12 transmembrane and secreted isoforms promote
breast tumor growth: A distinct role for ADAM12-S protein in tumor
metastasis. J Biol Chem. 286:20758–20768. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yang J, Bielenberg DR, Rodig SJ, Doiron R,
Clifton MC, Kung AL, Strong RK, Zurakowski D and Moses MA:
Lipocalin 2 promotes breast cancer progression. Proc Natl Acad Sci
USA. 106:3913–3918. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lamouille S, Xu J and Derynck R: Molecular
mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell
Biol. 15:178–196. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kumar A, Coleman I, Morrissey C, Zhang X,
True LD, Gulati R, Etzioni R, Bolouri H, Montgomery B, White T, et
al: Substantial interindividual and limited intraindividual genomic
diversity among tumors from men with metastatic prostate cancer.
Nat Med. 22:369–378. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Rousseau-Merck MF, Huebner K, Berger R and
Thiesen HJ: Chromosomal localization of two human zinc finger
protein genes, ZNF24 (KOX17) and ZNF29 (KOX26), to 18q12 and
17p13-p12, respectively. Genomics. 9:154–161. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Noll L, Peterson FC, Hayes PL, Volkman BF
and Sander T: Heterodimer formation of the myeloid zinc finger 1
SCAN domain and association with promyelocytic leukemia nuclear
bodies. Leuk Res. 32:1582–1592. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Harper J, Yan L, Loureiro RM, Wu I, Fang
J, D'Amore PA and Moses MA: Repression of vascular endothelial
growth factor expression by the zinc finger transcription factor
ZNF24. Cancer Res. 67:8736–8741. 2007. View Article : Google Scholar : PubMed/NCBI
|
